Treatment of AL amyloidosis with bendamustine: a study of 122 patients.

Mednet Member

Medical Oncology · Mayo Clinic Rochester

Achieving an early hem deep response (at least VGPR or better) is crucial for organ response and has demonstrated OS benefit.I would favor changing treatment even by cycle 4 if the hematologic response is <PR. Early switch in such situations led to improved EFS and better chances for an organ respon...